1-8 of 8
Marcin Rymko
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

An open-label, Phase I/II clinical trial of romaciclib (RVU120) as monotherapy and in combination with ruxolitinib in patients with intermediate or high-risk, primary or secondary myelofibrosis (POTAMI-61)

Free
Tomasz Sacha, Marcin Rymko, Katarzyna Dulik, Sebastian Grosicki, Rostislav Kuklík, Adam Falkowski, Nemanja Nikic, Gary Wilkinson, Ewelina Kowalewska, Agnieszka Szymula, Milena Mazan, Agnieszka Sroka-Porada, Tomasz Rzymski, Hendrik Nogai, Marta Sobas, Tomasz Wrobel, Aneta Szudy-Szczyrek
Journal: Blood
Blood (2025) 146 (Supplement 1): 2045.
https://doi.org/10.1182/blood-2025-2045
Published: 2025
Journal Articles

Carfilzomib, lenalidomide, and dexamethasone (KRd) versus bortezomib, lenalidomide and dexamethasone (VRd) in patients with newly diagnosed multiple myeloma (NDMM) – interim results from the randomized Phase III COBRA trial.

Free
Dominik Dytfeld, Tadeusz Kubicki, Agata Tyczynska, Marcin Rymko, Krzysztof Jamroziak, Fredrik Schjesvold, Jaroslaw Piszcz, Tomasz Wrobel, Krzysztof Giannopoulos, Bartosz Pula, Agnieszka Konska, Pawel Steckiewicz, Juha Lievonen, Mateusz Ziarkiewicz, Pawel Bernatowicz, Lidia Gil, Anna Lojko-Dankowska, Magdalena Matuszak, Jan Zaucha, Maria Czyzewska, Kamil Wisniewski, Magdalena Olszewska-Szopa, Anna Pula, Frank Wen, Frida Bugge Askeland, Valdas Peceliunas, Jennifer Cooperrider, Ken Jiang, Theodore Karrison, Benjamin Derman, Andrzej Jakubowiak
Journal: Blood
Blood (2025) 146 (Supplement 1): 99.
https://doi.org/10.1182/blood-2025-99
Published: 2025
Journal Articles

Minimal residual disease-guided venetoclax plus rituximab for patients with previously untreated chronic lymphocytic leukemia (VERITA PALG-CLL5): primary endpoint analysis of the prospective, multicenter, Phase 2 trial

Free
Krzysztof Jamroziak, Elzbieta Iskierka-Jazdzewska, Tadeusz Robak, Klaudia Zielonka, Sebastian Giebel, Kamil Wisniewski, Joanna Drozd-Sokolowska, Justyna Rybka, Weronika Piszczek, Monika Joks, Anna Dabrowska-Iwanicka, Andrzej Mital, Pawel Steckiewicz, Ewa Lech-Marańda, Marcin Jasinski, Marcin Rymko, Dawid Marciniak, Tomasz Wrobel, Lidia Gil, Joanna Romejko-Jarosinska, Dorota Kruk-Kwapisz, Agnieszka Chudy, Marcin Machnicki, Krzysztof Giannopoulos, Tomasz Stoklosa, Tomasz Górecki, Bartosz Pula
Journal: Blood
Blood (2025) 146 (Supplement 1): 5675.
https://doi.org/10.1182/blood-2025-5675
Published: 2025
Journal Articles

MRD-Driven Venetoclax and Rituximab Combination in Previously Untreated Chronic Lymphocytic Leukemia: First Results of the Prospective, Multicenter, Phase II Trial of the Polish Adult Leukemia Group (VERITA PALG-CLL5)

Free
Krzysztof Jamroziak, Elzbieta Iskierka-Jazdzewska, Sebastian Giebel, Kamil Wisniewski, Joanna Drozd-Sokolowska, Tadeusz Robak, Justyna Rybka, Weronika Piszczek, Monika Joks, Anna Paulina Dabrowska-Iwanicka, Andrzej Mital, Paweł Steckiewicz, Ewa Lech-Maranda, Marcin Jasinski, Marcin Rymko, Dawid Marciniak, Tomasz Wrobel, Lidia Gil, Joanna Romejko-Jarosinska, Dorota Kruk-Kwapisz, Agnieszka Chudy, Krzysztof Giannopoulos, Tomasz Stoklosa, Bartosz Michal Pula
Journal: Blood
Blood (2024) 144 (Supplement 1): 3242.
https://doi.org/10.1182/blood-2024-201076
Published: 2024
Journal Articles

Impact of Drug Transporters ABCB1 and ABCG2 and Regulators of Xenobiotic Transport and Metabolism Pxr and CAR Gene Polymorphisms on Clinical Efficacy of Imatinib in Chronic Myeloid Leukemia (CML)

Free
Anna Stepien, MSc, Alessandro Martino, PhD, Federico Canzian, PhD, Daniele Campa, PhD, Angelika Stein, Joanna Gora-Tybor, MD PhD, Tomasz Sacha, MD PhD, Dorota Link-Lenczowska, PhD, Izabela Florek, PhD, Witold Prejzner, MD PhD, Zofia Specht-Szwoch, Malgorzata Calbecka, MD PhD, Marcin Rymko, MD PhD, Marek Dudzinski, MD PhD, Pawel Gaj, PhD, Tadeusz Robak, MD, Krzysztof Warzocha, MD PhD, Krzysztof Jamroziak, MD PhD
Journal: Blood
Blood (2014) 124 (21): 5222.
https://doi.org/10.1182/blood.V124.21.5222.5222
Published: 2014
Journal Articles

Cereblon ( CRBN) Gene Polymorphisms Predict Clinical Response and Progression-Free Survival in Multiple Myeloma Patients Treated with Lenalidomide: A Pharmacogenetic Study of Immense Consortium

Free
Elzbieta Iskierka-Jazdzewska, MD, Anna Stepien, MSc, Federico Canzian, PhD, Alessandro Martino, PhD, Daniele Campa, PhD, Angelika Stein, Malgorzata Krawczyk-Kulis, MD PhD, Malwina Rybicka, MD PhD, Slawomira Kyrcz-Krzemien, MD PhD, Aleksandra K. Butrym, MD PhD, Grzegorz Mazur, MD PhD, Artur J. Jurczyszyn, MD PhD, Daria Zawirska, MD PhD, Norbert Grzasko, MD PhD, Waldemar Tomczak, MD PhD, Edyta Subocz, MD PhD, Marzena Watek, MD, Marcin Pasiarski, MD PhD, Marcin Rymko, MD PhD, Malgorzata Calbecka, MD PhD, Agnieszka Druzd-Sitek, PhD, Jan Walewski, MD PhD, Marcin Kruszewski, MD PhD, Malgorzata Razny, MD PhD, Jan M Zaucha, MD PhD, Marek Dudzinski, MD PhD, Pawel Gaj, PhD, Krzysztof Warzocha, MD PhD, Krzysztof Jamroziak, MD PhD
Journal: Blood
Blood (2014) 124 (21): 3628.
https://doi.org/10.1182/blood.V124.21.3628.3628
Published: 2014
Journal Articles

Efficacy Of Lenalidomide Treatment In Multiple Myeloma (MM) Patients – a Report of Polish Myeloma Group

Free
Lidia Usnarska-Zubkiewicz, Jakub Debski, MD, Aleksandra K. Butrym, MD, PhD, Wojciech Legiec, Marek Hus, MD, PhD, Anna Dmoszynska, Beata Stella-Holowiecka, MD, Jan M Zaucha, Marcin Rymko, MD, Tigran Torosian, MD, Grzegorz Charlinski, Ewa Lech-Maranda, Artur J. Jurczyszyn, MD, PhD, Halina Urbanska-Rys, Agnieszka Druzd-Sitek, PhD, Kazimierz Kuliczkowski
Journal: Blood
Blood (2013) 122 (21): 3236.
https://doi.org/10.1182/blood.V122.21.3236.3236
Published: 2013
Journal Articles

Efficacy and Safety of Lenalidomide in the Treatment of Multiple Myeloma (MM) Patients: a Preliminary Report of Polish Myeloma Group

Free
Lidia Usnarska-Zubkiewicz, MD, Jakub Debski, MD, Aleksandra Butrym, MD, Wojciech Legiec, MD, Anna Dmoszynska, Beata Stella-Holowiecka, MD, Jan Maciej Zaucha, MD, Marcin Rymko, MD, Tigran Torosian, MD, Kazimierz Kuliczkowski
Journal: Blood
Blood (2011) 118 (21): 5125.
https://doi.org/10.1182/blood.V118.21.5125.5125
Published: 2011